drug

varenicline (CP-526,555)

as of 2026-07-01
Add to landscapeMonitor thisCompare thisAsk about this
at a glance
small molecule
Pre-approval / investigational in the US
Developed by Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
1 trials in the graph
Synthesized from structured facts only — each point cited above.

Mechanism & identity

Modality
small molecule

Indications

Investigational (via trials)
Smoking CessationSmoking Cessation

Trials

1
Smoking Cessation Study for Patients With Schizophrenia or Schizoaffective Disorder
NCT00644969Phase 3Completed

Facts & assertions

0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
developer
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
company
trial
Smoking Cessation Study for Patients With Schizophrenia or Schizoaffective Disorder
PHASE3
trial
indication
Smoking Cessation
indication
Smoking Cessation
indication